FDA Approves Moderna and Pfizer COVID Boosters for Omicron and Variants

The FDA has approved updated COVID boosters from Moderna and Pfizer, targeting the omicron subvariant and other related variants. The shots could be administered later this week pending CDC approval. The FDA has also updated its guidelines on COVID vaccines, stating that individuals aged 5 and above can receive a single dose regardless of previous vaccinations. Both the Moderna and Pfizer vaccines are effective against currently circulating COVID variants, and doctors recommend getting a booster if you haven't received one since last fall and haven't had COVID recently.